ARCHIVES

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

HRT Doesn’t Raise Cancer Risk Following Oophorectomy

October 28, 2005

Senate Orders OMB T Increase NIH FTEs, Drop Rules On Apportionment

September 19, 1986

Government Remains open Under Budget Agreement; New Deadlines Are Oct. 5 & 19

October 5, 1990

PRI, Fending Off More Giants, Reportedly wins New operations. Support contract at Frederick

July 10, 1987

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

SmithKline Seeks FDA Action Against Homeopathic Smoking-Cessation Gum

March 6, 1998